Status:
COMPLETED
Treatment of Oral Warts in HIV+ Patients
Lead Sponsor:
Ainos, Inc. (f/k/a Amarillo Biosciences Inc.
Conditions:
Papillomatosis
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This is a study to test lozenges of interferon-alpha that are dissolved in the mouth as a treatment of oral warts in HIV-positive adults. The hypothesis of this study is that interferon-alpha will be...
Detailed Description
Human papilloma virus (HPV) can cause warts to form in the mouth of infected patients, particularly those with reduced immunity such as people infected with HIV. This is a randomized, double-blind, pl...
Eligibility Criteria
Inclusion
- Must have tested positive for HIV.
- Must have two or more warts inside the mouth.
- Must be receiving a standard course of anti-retroviral therapy (HAART).
Exclusion
- Must not be receiving oral or injected steroids.
- Must not be taking other drugs for treatment of oral warts.
- Must not have other active HIV-related opportunistic infections.
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT00454181
Start Date
February 1 2007
End Date
October 1 2009
Last Update
September 16 2011
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, School of Dentistry
San Francisco, California, United States, 94143
2
Nova Southeastern University College of Dental Medicine
Fort Lauderdale, Florida, United States, 33328-2018
3
Medical College of Georgia School of Dentistry
Augusta, Georgia, United States, 30912-1241
4
University of Illinois at Chicago, College of Dentistry
Chicago, Illinois, United States, 60612